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In recent years, the potential of cartilage tissue engineering
techniques employing mesenchymal stem cells (MSCs) to
repair damaged human cartilage and defects has generated
much interest. Traditionally, sources of MSCs included
patient’s own bone marrow. However, little have been
reported on adult peripheral blood (PB) as a source of
MSCs, which has been a subject of much debate amongst
scientists owing to its extremely low density in PB and the
difficulties associated with extracting MSCs from PB. The
objectives of this study were to isolate MSCs derived from
bone marrow and peripheral blood as a source and to assess
their potential to undergo in vitro chondrogenesis using a
biocompatible three-dimensional scaffold. In defining
MSCs, the cells isolated from its source must meet these 3
criteria: (i) adherence to plastic when maintained in culture;
(ii) positive expression of several antigens such as CD29,
CD105, CD166; (iii) ability to differentiate into osteoblasts,
adipocytes & chondrocytes under in vitro inductive condi-
tions. PB samples (2 ml) were collected and mononuclear
cells extracted and separated using Ficoll–Paque PLUS via
centrifugation. Subsequently, suspended cells were removed
after 5 days of culture, and adherent cells left to grow. Cells
were detached upon reaching 80-90% confluence and sub-
cultured up to 4 passages prior to further experiments.
MSC antigens were recognized by monoclonal antibodies
CD29, CD105 and CD166. To distinguish MSCs from
hematopoietic stem cells, CD34 surface markers were used
as negative controls. The characterized human blood-
derived progenitor cells were cultured in three-dimensional
alginate scaffolds using chondrogenic induction medium to
promote chondrogenesis. Chondrogenesis was quantitated
by sulphated glycosaminoglycan (S-GAG) production mea-
sured by 1,9-dimethylmethylene blue (DMMB) assay.
Furthermore, chondrogenic-MSCs were examined and his-
tologically compared using Safranin O staining to that of
human chondrocytes as a means to determine chondro-
genic transformation. Gene expression analysis was carried
out by reverse transcriptase-polymerase chain reaction (RT-
PCR) of differentiated human blood-derived progenitor
cells using chondrocyte (cartilage cell)-specific phenotypic
markers. The results showed that the cell derived in our
processing technique share similar characteristics with adult
MSCs and chondrocytes. Induction of chondrogenesis has
been demonstrated in human blood-derived progenitor
cells, which could provide a ready source of chondrocytes
for engineering biological therapies. In the practical sense,
PB isolation would prove to be less invasive, less expensive
and less traumatic for patients to undergo therapy as com-
pared to the 2-stage procedure of current available tissue
engineering technique.
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